These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 19471236)

  • 21. The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors.
    Liu T; Brown TC; Juhlin CC; Andreasson A; Wang N; Bäckdahl M; Healy JM; Prasad ML; Korah R; Carling T; Xu D; Larsson C
    Endocr Relat Cancer; 2014 Jun; 21(3):427-34. PubMed ID: 24803525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
    Pacak K; Eisenhofer G; Ahlman H; Bornstein SR; Gimenez-Roqueplo AP; Grossman AB; Kimura N; Mannelli M; McNicol AM; Tischler AS;
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):92-102. PubMed ID: 17237836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pheochromocytomas and paragangliomas: implications of new insights for diagnosis and treatment].
    van der Kleij-Corssmit EP; Havekes B; Vriends AH; Jansen JC; Romijn JA
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):489-93. PubMed ID: 18389879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic guidelines for adrenal gland nodules: typing, assessment of biological potential and prognosis, molecular pathogenesis].
    Schröder S; Padberg B; Reincke M; Komminoth P
    Verh Dtsch Ges Pathol; 1997; 81():97-102. PubMed ID: 9474859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center.
    Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF
    Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The genetic basis of pheochromocytoma and paraganglioma: implications for management.
    Shuch B; Ricketts CJ; Metwalli AR; Pacak K; Linehan WM
    Urology; 2014 Jun; 83(6):1225-32. PubMed ID: 24642075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular aspects of adrenal tumours.
    McNicol AM
    Minerva Endocrinol; 1995 Mar; 20(1):9-13. PubMed ID: 7651288
    [No Abstract]   [Full Text] [Related]  

  • 28. The occurrence of SDHB gene mutations in pheochromocytoma.
    Van Nederveen FH; Dinjens WN; Korpershoek E; De Krijger RR
    Ann N Y Acad Sci; 2006 Aug; 1073():177-82. PubMed ID: 17102084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adrenal tumors.
    Rubello D; Gross MD
    Minerva Endocrinol; 2009 Jun; 34(2):105. PubMed ID: 19471235
    [No Abstract]   [Full Text] [Related]  

  • 30. Pheochromocytomas: from genetic diversity to new paradigms.
    Qin Y; Buddavarapu K; Dahia PL
    Horm Metab Res; 2009 Sep; 41(9):664-71. PubMed ID: 19391076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [How genomics upsets understanding of adrenal tumors?].
    Assié G
    Rev Prat; 2016 May; 66(5):539-545. PubMed ID: 30512579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of novel germline deletions affecting SDHD and SDHC in pheochromocytoma and paraganglioma patients.
    Bayley JP; Weiss MM; Grimbergen A; van Brussel BT; Hes FJ; Jansen JC; Verhoef S; Devilee P; Corssmit EP; Vriends AH
    Endocr Relat Cancer; 2009 Sep; 16(3):929-37. PubMed ID: 19546167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phaeochromocytoma in children.
    Armstrong R; Sridhar M; Greenhalgh KL; Howell L; Jones C; Landes C; McPartland JL; Moores C; Losty PD; Didi M
    Arch Dis Child; 2008 Oct; 93(10):899-904. PubMed ID: 18499773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular basis of adrenocortical carcinomas.
    Soon PS; Sidhu SB
    Minerva Endocrinol; 2009 Jun; 34(2):137-47. PubMed ID: 19471238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pheochromocytoma: current approaches and future directions.
    Adler JT; Meyer-Rochow GY; Chen H; Benn DE; Robinson BG; Sippel RS; Sidhu SB
    Oncologist; 2008 Jul; 13(7):779-93. PubMed ID: 18617683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of pheochromocytoma and paraganglioma: new developments.
    Pigny P; Cardot-Bauters C
    Ann Endocrinol (Paris); 2010 Mar; 71(2):76-82. PubMed ID: 20031114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathways linking the pheochromocytoma susceptibility genes.
    Leow MK
    Pediatr Blood Cancer; 2007 Dec; 49(7):1050-1; author reply 1052-3. PubMed ID: 17243134
    [No Abstract]   [Full Text] [Related]  

  • 39. What Have We Learned from Molecular Biology of Paragangliomas and Pheochromocytomas?
    Papathomas TG; Suurd DPD; Pacak K; Tischler AS; Vriens MR; Lam AK; de Krijger RR
    Endocr Pathol; 2021 Mar; 32(1):134-153. PubMed ID: 33433885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An Update on the Histology of Pheochromocytomas: How Does it Relate to Genetics?
    Oudijk L; Gaal J; Koopman K; de Krijger RR
    Horm Metab Res; 2019 Jul; 51(7):403-413. PubMed ID: 30142639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.